Fueyo et al. suggested that O6-methyl guanine -DNA methyl transferase (MGMT) was responsible for resistance of glioma cells to TMZ and therefore MGMT expression formed the basis for clinical treatment strategies. Here, MGMT is linked to central nervous system cancer.